<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SII-42371</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Siegfried-Col</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Financing to Laboratorios Siegfried S.A.S (Siegfried-Col) and Laboratorios Siegfried, S.A. (jointly the Borrowers) to support the execution of their strategic plan including: (i) Capex needed to upgrade the manufacturing plant owned by Siegfried-Col, (ii) working capital requirements for the commercialization of Novartis products in light of the recent license-in agreement signed between the Borrowers and Novartis; and (iii) reprofile the Borrowers existing debt with commercial banks to properly match the long-term nature of the investments undertaken by the Borrowers over the past years and free-up the cash needed to execute their strategic plan within the next 2-3 years (the Project). Siegfried-Col is a leading pharmaceutical company focused on the development, manufacture and commercialization of over-the-counter medicines, prescription drugs and personal care products (mostly branded generics). With two manufacturing plants in Colombia and 516 employees, Siegfried-Col is focused mainly on cardio, neuro, womens health and primary care therapeutic areas. Approximately 95% of Siegfried-Cols revenues are generated in Colombia, and the rest is exported to Central America, Ecuador, and Peru.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">This Project is being processed under the Global Health
Platform (GHP).      

  Project-level:       

 Stakeholder effect: Increased Access to Healthcare Products.
By financing the Project, IFC expects to benefit the middle-to-low income
population in Colombia, Peru, Ecuador, and Central America from lower priced
high-specialty medicines, consistent and high quality, and greater product
variety.     

 Economy-wide effect: Gross Value-Added  IFC financing will
support a manufacturer located in Colombia. The project will help scale the
production and delivery of healthcare supplies that is likely to result in the
creation of new jobs and/or economic linkages to the rest of the economy.     

  Market Creation:      

 Beyond the project, IFC anticipates that its financing could
support greater market resilience as spillover effects accrue to the healthcare
supply chains in these markets.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">LABORATORIOS SIEGFRIED S.A.</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SII-42371" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="1"></activity-status>
  <activity-date iso-date="2022-04-21" type="1"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">0  0  0  0  0  0  0  0  0.0000         Mr. Hern&#xE1;n Collard    Chief Financial Officer    Tel:   0571-2086262     hcollard@siegfried.com.co     Laboratorios Siegfried S.A.S    CL 17 #42-09, Bogot&#xE1;, Colombia</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Laboratorios Siegfried S.A.S.  Mr. Hern&#xE1;n Collard  Chief Financial Officer  0571-2086262  hcollard@siegfried.com.co  CL 17 #42-09, Bogot&#xE1;, Colombia  www.siegfried.com.co</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="CO" percentage="100">
   <narrative xml:lang="EN">Colombia</narrative>
  </recipient-country>
  <location ref="CO-Colombia">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">Colombia and Panama.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>4.0000000000 -73.2500000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">other</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $30.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2022-04-21"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2022-04-21">30000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-04-21"></transaction-date>
   <value currency="USD" value-date="2022-04-21">30000000</value>
   <receiver-org>
    <narrative xml:lang="EN">LABORATORIOS SIEGFRIED S.A.</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42371/siegfriedcol">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information - Anticipated Impact Measurement &amp; Monitoring (AIMM) Assessment and Main Environmental &amp; Social Risks and Impacts of the Project</narrative>
   </title>
   <category code="A01"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SII/42371/siegfriedcol">
   <title>
    <narrative xml:lang="EN">Summary of Investment Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
